Stocks Down Under Videos
Get a 3-month FREE TRIAL to CONCIERGE now!
Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Noxopharm (ASX:NOX): Interview with CEO Graham Kelly
August 19, 2020
NOX, Noxopharm, video
We talked with Graham Kelly about Noxopharm’s clinical success with Veyonda and in particular its synergies with radiation therapy. Veyonda is a drug that seems to work in a wide variety of cancers.